RVMD
Revolution Medicines·NASDAQ
--
--(--)
--
--(--)
RVMD fundamentals
Revolution Medicines (RVMD) released its earnings on Nov 5, 2025: revenue was 0 (YoY 0.00%), missed estimates; EPS was -1.61 (YoY -71.28%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.61
-71.28%
Report date
Nov 5, 2025
RVMD Earnings Call Summary for Q3,2025
- Pancreatic Cancer Breakthrough: Daraxonrasib Phase III data show 13.1-15.6 months OS in second-line PDAC,优于化疗的6-7个月。FDA vouchers可能加速审批。
- First-Line Potential: First-line daraxonrasib单药和化疗组合分别达到47%和55%的ORR，耐受性良好。
- Lung Cancer Expansion: Elironrasib在晚期NSCLC中实现42% ORR；daraxonrasib + pembrolizumab组合进入注册试验。
- Financial Strength: $1.93B现金支持临床和商业化扩张，2025年净亏损指引为$1.03-1.09B。
- Commercial Momentum: 美国和欧洲区域负责人就位，加速全球上市准备。
EPS
Revenue
Revenue & Expenses
Key Indicators
Revolution Medicines (RVMD) key financial stats and ratios, covering profitability, financial health, and leverage.
Revolution Medicines (RVMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Revolution Medicines (RVMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Revolution Medicines (RVMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Revolution Medicines (RVMD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Revolution Medicines (RVMD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Revolution Medicines year over year?What guidance did Revolution Medicines's management provide for the next earnings period?What were the key takeaways from Revolution Medicines's earnings call?What does Revolution Medicines do and what are its main business segments?What were the key takeaways from Revolution Medicines’s earnings call?What factors drove the changes in Revolution Medicines's revenue and profit?What is the market's earnings forecast for Revolution Medicines next quarter?What is Revolution Medicines's gross profit margin?
